Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Naila Z.

Qatar

USD 100 /hr

PhD | Helping Biotech Turn Complex Omics into Strategic Advantage | AI-Driven Biomarker & Drug Discovery Consultant

Profile Summary

Advancing Biomarker & Drug Discovery Strategy Through AI I help biotech teams, research groups, and translational innovators transform complex biological data into clear, strategic decisions. By integrating bioinformatics, multi-omics analysis, and AI-driven workflows, I bridge the gap between discovery science and clinical impact. Modern biomedical research generates enormous volumes of data but data alone does not create progress. Insight, structure, and strategy do. That is where I come in. Some reach out early months before a major milestone wanting a strategic partner to design a rigorous, AI-augmented biomarker and target discovery roadmap aligned with their scientific and business goals. Others come when complexity has started to slow progress data is fragmented, analyses are inconsistent, insights are unclear, and decision-making lacks confidence. How I Help I support teams by: Building reproducible multi-omics pipelines for discovery and translational research Developing biomarker scoring and prioritization frameworks for clinical relevance Integrating pathway, network, and causal evidence for target discovery Applying AI and agentic workflows to automate complex bioinformatics tasks Translating computational outputs into clear biological and therapeutic narratives Why Me? My work sits at the intersection of bioinformatics, AI systems, and translational strategy. I’ve built modular, reproducible pipelines that combine statistical rigor, network biology, causal inference, and knowledge-graph reasoning to move from raw omics data to confident biological decisions. I understand that insight alone is not enough it must align with clinical timelines, regulatory expectations, and business strategy. I built my consulting practice around one principle: Clear, structured, AI-enhanced strategy prevents expensive missteps. My clients don’t get generic analyses. They get a tailored, systems-level approach designed for their specific drug, dataset, and development stage. If you’re advancing a therapeutic program and need a rigorous, efficient, and future-ready data strategy especially when every decision matters, let’s talk.

Subject Matter Expertise

• ☆ Molecular Modeling
• ☆ Molecular Docking
• ☆ Biochemistry
• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Omics
• ☆ Gene Regulation
• ☆ Automation
• ☆ Bioinformatics
• ☆ Biomarker Discovery
• ☆ Pharmacy
• ☆ Drug Discovery
• ☆ Vaccine Development
• ☆ Biomarker Analysis
• ☆ Infectious Disease
• ☆ Viral Diseases
• ☆ Pharmaceutical Management

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Clinical Trial Documentation, Medical Writing

Research Meta-Research, Gap Analysis, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

Consulting Healthcare Consulting, Scientific and Technical Consulting

Data & AI Image Processing, Image Analysis, Data Visualization, Data Mining, Data Processing, Data Insights

Work Experience

Senior Team Lead | Strategic Lead

Ayass Bioscience

March 2024 - Present

Education

PhD

Quaid-i-Azam University

February 2018 - October 2023

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Zaman N, Gul K, Khurram K, Azam SS (2025). Molecular insights into pangenome localization and constructs design for Hemophilus influenza vaccine . Scientific reports.

Naila Zaman, Syed Sikander Azam (2023). Discrete Dynamics of Warhead Modulation on Covalent Inhibition of Oxyr: A QM/MM Study . The Journal of Physical Chemistry B.

Naila Zaman, Syed Sikander Azam (2023). Quantum Dynamics and Bi Metal Force Field Parameterization Yielding Significant Antileishmanial Targets . Journal of Chemical Information and Modeling.

Naila Zaman (2023). Modulating structural dynamics of dual drugs for CDK4 complex addressing prostate cancer . Journal of Molecular Liquids.

Naila Zaman, Kainat Gul, Syed Sikander Azam(2023). Roxadustat and its failure: A comparative dynamic study . Journal of Molecular Graphics and Modelling. p. 108422. Elsevier {BV}

Naila Zaman, Chandrabose Selvaraj, Nousheen Parvaiz, Rabia Farid, Afifa Navid, Ghulam Abbas, Syed Sikander Azam (2022). Senna makki and other active phytochemicals: Myths and realities behind covid19 therapeutic interventions . PLOS ONE.

Sohaila Andleeb and Imtiaz-ud-Din and Muhammad Khawar Rauf and Syed Sikander Azam and Ihsan-ul Haq and Muhammad Nawaz Tahir and Naila Zaman(2022). Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies . JBIC Journal of Biological Inorganic Chemistry. 27. (1). p. 175--187. Springer Science and Business Media {LLC}

Azka Ahmed and Naila Zaman and Syed Sikander Azam(2020). Deciphering the role of sulfonamides and molecular basis of thioredoxin domain dynamics through comparative simulations . Journal of Molecular Liquids. p. 114797. Elsevier {BV}

Sajjad Ahmad and Afifa Navid and Rabia Farid and Ghulam Abbas and Faisal Ahmad and Naila Zaman and Nousheen Parvaiz and Syed Sikander Azam(2020). Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics . European Journal of Pharmaceutical Sciences. 151. p. 105387. Elsevier {BV}

Naila Zaman and Syed Sikander Azam(2020). From normal to competo-allosteric regulation: insights into the binding pattern dynamics of DSPI protein of Pseudomonas aeruginosa . Journal of Biomolecular Structure and Dynamics. p. 1--20. Informa {UK} Limited

S. Sikander Azam and Ayman Saroosh and Naila Zaman and Saad Raza(2013). Role of N-acetylserotonin O-methyltransferase in bipolar disorders and its dynamics . Journal of Molecular Liquids. 182. p. 25--31. Elsevier {BV}